FDA Approved: RELPAX — Supplemental Application (ROERIG)

View source ↗

Summary

FDA approves a supplemental application for RELPAX (eletriptan hydrobromide) submitted by ROERIG. This approval relates to an existing RELPAX product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• RELPAX (Eletriptan hydrobromide)

Snippet

SUPPL AP for RELPAX (ELETRIPTAN HYDROBROMIDE)